Komori
The Japan Wool Textile (3201) · InitiativeAdvanced

Developing New Business Areas Including Medical-Related Businesses

First written in FY2018. 4 of 6 entries say "Advanced", first in FY2019. Latest entry: FY2025.

6entries
8years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2018AdvancedFY2019 – FY2020RestatedFY2021AdvancedFY2023 – FY20252019: 120192020: 120202021: 120212022: 120222023: 020232024: 120242025: 020252026: 1
Same theme, other companies
Creation and Development of New and Growth BusinessesA theme 186 companies write about · 0 as a headwind · 197 as a tailwind

103 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 186 companies compared. The sentences above are computed from all 186.
Full recordFilings, disclosures and news, newest first
  1. FY2025AdvancedAnnual report

    「We focused on expanding sales of new products launched in the previous fiscal year, including the bioabsorbable sheet "Pawdre®," the multiport for laparoscopic surgery "Dome Port™," and the ultrasound examination support device "COMPASS guide."」

    In the medical field, Pawdre and other new products moved into the sales expansion phase following their market launch, while the company also advanced industry-academia collaborative clinical research and verification of market needs using Genocel.
  2. FY2023AdvancedAnnual report

    「The bioabsorbable sheet "Ｐａｗｄｒｅ" received regulatory approval, but approval was later than initially planned, and we expect it to contribute to results from fiscal 2024 onward.」

    In the medical-related business, the company obtained regulatory approval for the bioabsorbable sheet "Ｐａｗｄｒｅ." Although approval was later than planned, the product has reached the stage where it is expected to contribute to results from fiscal 2024 onward.
  3. FY2021RestatedAnnual report

    「We aim to monetize products developed using the NIKKE Group's technologies and strengthen our capabilities as a manufacturer.」

    In the medical-related business, the company continues to aim to monetize products developed using the group's technologies and strengthen its manufacturing capabilities.
  4. FY2020AdvancedAnnual report

    「<Medical-related business> ・Monetization of products under development」

    For the medical-related business, the company presented the monetization of products under development as a specific measure under the Second Medium-Term Management Plan, moving beyond its previous policy of development through M&A and research and development.
  5. FY2019AdvancedAnnual report

    「April 2019 Acquired ㈱京都医療設計, a medical-device distributor, as a subsidiary (currently a consolidated subsidiary)」

    In line with its policy of developing new business areas, including medical-related businesses, the company acquired a medical-device distributor as a subsidiary in April 2019.
  6. FY2018First statedAnnual report

    「In addition to entering new businesses and strengthening existing businesses through M&A, the company will advance research and development in growth fields one step ahead of its existing businesses and foster new business areas, including medical-related fields.」

    The company has indicated a policy of developing new business areas, including medical-related businesses, through M&A and research and development.
Moved together

"Shareholder Returns through Dividends" moved the same way as this thread, in the same document, in 4 of its 6 moves.

444444★123456
  1. ★This thread
  2. 1Shareholder Returns through Dividends4×
  3. 2Rebuilding the Management Strategy for the Next 10 Years under the RN130 Vision4×
  4. 3人とみらい開発, centered on community-based services and urban development4×
  5. 4Expansion of Overseas Business4×
  6. 5Improving Asset Efficiency4×
  7. 6Developing and Expanding Sales of Materials and Automation Machinery by Capitalizing on Autonomous Driving and EV Adoption4×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for The Japan Wool Textile yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Developing New Business Areas Including Medical-Related Businesses | THE JAPAN WOOL TEXTILE CO.,LTD. (3201) | Komori